Searchable abstracts of presentations at key conferences in endocrinology

ea0048wc4 | Workshop C: Disorders of the thyroid gland | SFEEU2017

A difficult to manage eye disease

Plichta Piotr , Randall Joanne

A 61-year-old ex-smoker with a background of chronic obstructive pulmonary disease, bilateral cataracts and advanced retinitis pigmentosa presented in April 2014 with a 5 months history of feeling generally unwell and weight loss. He was found thyrotoxic with TSH suppressed to less than 0.01 mU/l, free T4 of 38 pmol/l and free T3 of 26 pmol/l. On examination there was tunnel vision bilaterally and diplopia in all directions with no evidence of thyroid eye...

ea0025p333 | Thyroid | SFEBES2011

Audit of thyroid function testing in patients on amiodarone

Srinivas Vidya , Srinivasan Ramalingam , Randall Joanne

Objective: Amiodarone is an iodine rich, potent antiarrhythmic drug that is highly lipid soluble and total body iodine stores remain increased for up to 9 months. Abnormal thyroid functions, either thyrotoxicosis or hypothyroidism occur in upto 14–18% of patients receiving long-term amiodarone therapy. Hence regular thyroid function tests are required in patients on long-term amiodarone treatment. The BNF clearly states that thyroid function tests should be done at a mini...

ea0048cp18 | Poster Presentations | SFEEU2017

An elusive parathyroid gland

Plichta Piotr , Randall Joanne , Di Marco Aimee , Palazzo Fausto

We describe a case of a male who presented to a rheumatologist with hypercalceamia at the age of 22 in 1995. Investigations were incomplete and he was lost to follow up. He was referred to a general surgeon in 2002 as another blood test had showed hypercalcaemia of 2.8 mmol/l (2.2–2.6), parathyroid hormone 9.5 pmol/l (1.6–6.9). A spot urine calcium/creatinine excretion ratio was 0.014. It was felt he probably had primary hyperparathyroidism and he was managed conserv...